Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04803877
Title SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sarcoma Alliance for Research through Collaboration
Indications
Therapies
Age Groups: adult | senior | child
Covered Countries USA

Facility Status City State Zip Country Details
Children's Hospital of Los Angeles Los Angeles California 90027 United States Details
University of Miami Miami Florida 33136 United States Details
Johns Hopkins Baltimore Maryland 21287 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
University of Minnesota Minneapolis Minnesota 55455 United States Details
Cincinnati Children's Cincinnati Ohio 45229 United States Details
Oregon Health and Sciences University Portland Oregon 97239 United States Details
UT Southwestern Medical Center Dallas Texas 75390 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field